Tag: Endologix

FDA advisory panel issues recommendations on lifelong surveillance for EVAR

The Food and Drug Administration (FDA) recently announced it has issued a letter to healthcare providers emphasizing the importance of lifelong surveillance, including imaging,...

FDA issues updated safety communication on use of Endologix AFX endovascular...

The Food and Drug Administration (FDA) has issued an updated safety communication on the use of Endologix AFX endovascular grafts. This update includes...

Endologix announces completion of enrollment in TORUS 2 study for PAD...

Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports. The TORUS 2 study...

VEITH 2021: Two-year follow-up data from EVAS2 IDE study delivered

The confirmatory EVAS2 clinical study to evaluate the safety and effectiveness of Endologix's Nellix endovascular aneurysm sealing system (EVAS) for the treatment of infrarenal...

Endologix launches randomized study of Alto EVAR device

Endologix today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the company’s Alto abdominal stent...

The top 10 most popular Vascular Specialist stories in July

The digital version of our July 2021 print issue, an argument in favor of a multidisciplinary approach to limb salvage and look back at...

Endologix receives FDA Breakthrough Device designation for ChEVAS system

Endologix announced the company’s ChEVAS (chimney endovascular aneurysm sealing) system has been granted a Breakthrough Device designation from the Food and Drug Administration (FDA). The...

Endologix announces launch of Alto abdominal stent graft in Canada

Endologix today announced the first implant of its Alto abdominal stent graft in Canada following recent approval from Health Canada. Alto was also recently...

Plans revealed for pilot study on performance of EVAR for AAA...

Details of a planned pilot study investigating the merits of performing endovascular aortic repair (EVAR) on abdominal aortic aneurysms (AAAs) in office-based labs (OBLs)...

PAD: Endologix acquires PQ Bypass

Endologix recently announced completing the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses severe peripheral arterial disease (PAD). PQ...

Endologix enters into agreement with Deerfield Partners to take company private

Endologix has announced that, after evaluating a variety of strategic options, it has initiated a voluntary Chapter 11 case and simultaneously filed a consensual...